Balaji Amines Q1 FY26 Results (NSE: BALAMINES)

· Analysis by Alpha Inflection

Signal: Margin expansion

The read

For Q1FY26, Balaji Amines delivered its 5th consecutive quarter of margin expansion, with EBITDA margin surging 960bps YoY to 26.3%. The primary driver was a sharp gross margin tailwind: raw material cost as % of revenue dropped 840bps to 55.5%, reflecting both input deflation and sustained pricing power (revenue grew 27% despite volume not disclosed – implied ASP/mix support). Fixed costs (employee + D&A) grew only 1.3% combined, providing strong operating leverage on a 27% revenue base. PAT nearly doubled to ₹7,811.77 lakh, with interest coverage at ~75x. The standalone vs consolidated gap (~₹600 lakh net profit in subsidiary) shows Balaji Speciality Chemicals contributed positively. No exceptional items, auditor unmodified opinion. The trajectory inflects sharply positive from the prior year's contractionary phase (Q1-Q3FY25).

Balaji Amines Q1 FY26 key financials
MetricValueYoYQoQ
Revenue₹455.93 Cr27.2%15.5%
EBIT₹106.2 Cr116.7%
Net profit₹78.12 Cr97.2%
EPS₹23.1397.2%
EBIT margin23.3%

P&L walk

Revenue jumped 27.2% YoY to ₹45,592.56 lakh, accelerating from -1.7% in Q2FY25 and +5.8% in Q3FY25; the 5th straight quarter of margin expansion saw EBITDA margin surge to 26.3% (+960bps YoY) driven by a massive gross margin tailwind (raw material cost fell 840bps to 55.5% of revenue) and stable opex ratios; PAT nearly doubled to ₹7,811.77 lakh as the operating leverage from 27% revenue growth on a flattish fixed-cost base amplified earnings.

Segments

Amines & Speciality Chemicals segment drove the results: revenue grew 26.7% YoY to ₹45,288.92 lakh, segment PBIT surged 132.4% YoY to ₹10,409.38 lakh, with margins expanding to 23.0% from 12.5%. Hotel division revenue fell 22.2% YoY but remained profitable (PBIT ₹153.93 lakh). The consolidated PAT of ₹7,811.77 lakh included ₹318.11 lakh attributable to non-controlling interests (subsidiary Balaji Speciality Chemicals).

Key positives

Key concerns

View original filing

Research and educational content only. Not investment advice.